Arrhythmia & Atrial Fibrillation in China
Overview
Arrhythmias are disorders of the heart’s electrical system in which the heart may beat too fast, too slowly or irregularly. Atrial fibrillation (AF), the most common sustained arrhythmia, raises stroke risk five-fold when untreated but is highly manageable with modern rate control, anticoagulation and ablation strategies.
Chinese electrophysiology laboratories perform among the world’s largest volumes of AF ablation, giving patients access to deeply experienced operators and the newest energy platforms.
Symptoms & Signs
Palpitations — a fluttering, racing or pounding sensation in the chest
Irregular pulse noticed at rest or discovered on a routine checkup ECG
Dizziness, breathlessness and reduced exercise tolerance
Fatigue and unexplained decline in stamina, particularly in older patients
Silent AF with no symptoms at all — still carrying stroke risk and requiring management
Dangerous fast rhythms (ventricular tachycardia) causing fainting or cardiac arrest in structural heart disease
Diagnosis
Resting 12-lead ECG and 24-hour Holter monitoring
Extended event recorders and implantable loop recorders for infrequent episodes
Electrophysiology study mapping the arrhythmia circuit in detail
Echocardiography assessing structural heart disease and atrial size
CHA2DS2-VASc stroke-risk scoring to guide anticoagulation decisions
Sleep apnea and thyroid screening, since both commonly trigger AF
Treatment Options
Rate-control medication (beta-blockers, calcium-channel blockers) and antiarrhythmic drug therapy
Anticoagulation to prevent stroke, with novel oral anticoagulants as first-line therapy
Left atrial appendage closure for patients who cannot take long-term anticoagulation
Catheter ablation — radiofrequency or cryoballoon — isolating the pulmonary veins for paroxysmal and persistent AF
Pacemaker implantation for slow rhythms, including physiological (conduction-system) pacing
ICD defibrillators and CRT resynchronization therapy for heart-failure patients with dangerous rhythms
Advanced Technologies & Novel Drug
3D electroanatomic mapping systems (CARTO-class) enabling precise lesion placement
Cryoballoon and pulsed-field ablation (PFA) — a newer energy source with improved safety margins
Leadless pacemakers and MRI-compatible device platforms
Robotic magnetic navigation for complex arrhythmia substrates
Domestically developed ablation catheters and novel antiarrhythmic agents available at leading EP centers
Hospital & Specialist
- Fuwai Hospital, Chinese Academy of Medical Sciences (Fuwai Hospital, CAMS & PUMC) — Beijing
- Zhongshan Hospital, Fudan University — Shanghai
- Tianjin Medical University General Hospital — Tianjin
- The Second Hospital of Tianjin Medical University — Tianjin
- Fang Quan — Cardiology
- Ni Chao — Cardiology
- Xu Jing — Cardiology
- Du Zhong Dong — Cardiology